Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine

Journal of Infectious Diseases

Volumn 175, Issue 4, 1997, Pages 871-875

  Kollaritsch, Herwig ^a   Que, John U ^b   Kunz, Christian ^b   Wiedermann, Gerhard ^b   Herzog, Christian ^b   Cryz Jr , Stanley J ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CHOLERA VACCINE; ORAL POLIOMYELITIS VACCINE; PROGUANIL; TYPHOID VACCINE; YELLOW FEVER VACCINE;

ACTIVE IMMUNIZATION; ADULT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CHOLERA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; FEMALE; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; MALAISE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SKIN ALLERGY; TYPHOID FEVER;

EID: 0030940032     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/513984     Document Type: Article

References (18)

1. Levine MM, Kaper J. Live vaccines against cholera: an update. Vaccine 1993;11:207-12.
2. Levine MM, Kaper J, Herrington D, et al. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet 1988;2:467-70.
3. Robbins FC. Polio - historical. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia: WB Saunders, 1994:137-54.
4. Kotloff KL, Wasserman SS, O'Donnel S, Losonsky GA, Cryz SJ Jr, Levine MM. Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized placebo-controlled, double-blind, crossover trial. Infect Immun 1992; 60:4430-2.
5. Cryz SJ Jr. Post-marketing experience with live oral Ty21a. Lancet 1990; 341:49-50.
6. Levine MM, Ferreccio C, Black RE, Tacket CO, Germanier R, Chilean Typhoid Committee. Progress in vaccines against typhoid fever. Rev Infect Dis 1989;11(suppl 3):S552-67.
7. Wolfe MS. Precautions with oral live typhoid (Ty21a) vaccine. Lancet 1990;336:631-2.
8. Horowitz H, Carbonaro CA. Inhibition of the Salmonella typhi oral vaccine strain, Ty21a, by mefloquine and chloroquine. J Infect Dis 1992;166: 1462-4.
9. Cryz SJ Jr, Que JU, Levine MM, Wiedermann G, Kollaritsch H. Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults. Infect Immun 1995;63:1336-9.
10. Kollaritsch H, Fürer E, Herzog C, Wiedermann G, Que JU, Cryz SJ Jr. Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines. Infect Immun 1996;64: 1454-7.
11. Pappaioanou M, Fishbein DB, Dreesen D, et al. Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine. N Engl J Med 1986;314:280-4.
12. Felsenfeld O, Wolf RH, Gyr K, et al. Simultaneous vaccination against cholera and yellow fever. Lancet 1973;1:457-8.
13. Clements ML, Levine MM, Young CR, Black RE, Lim YL, Robins-Browne RM. Magnitude, kinetics, and duration of vibriocidal antibody response in North Americans after ingestion of Vibrio cholerae. J Infect Dis 1982;145:465-73.
14. Levine MM, Herrington D, Murphy JR, et al. Safety, infectivity, immunogenicity and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi. 541 Ty and 543 Ty, as live oral vaccines in man. J Clin Invest 1987;79:888-902.
15. Reisinger EC, Grasmug E, Krejs GJ. Antibody response after vaccination against typhoid fever in Kurdish refugee camp. Lancet 1994;343: 918-9.
16. Clements JD, van Loon F, Sack DA, et al. Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera. J Infect Dis 1991;163:1235-42.
17. Tacket CO, Losonsky G, Nataro JP, et al. Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR. J Infect Dis 1992;166:837-41.
18. General recommendations on immunization. Recommendation of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1994;43(RR 1)1-38.